BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38683753)

  • 1. Identification of Potent and Selective Inhibitors of
    Hargrove TY; Lamb DC; Wawrzak Z; Hull M; Kelly SL; Guengerich FP; Lepesheva GI
    J Med Chem; 2024 May; 67(9):7443-7457. PubMed ID: 38683753
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterisation of sterol biosynthesis and validation of 14α-demethylase as a drug target in Acanthamoeba.
    Thomson S; Rice CA; Zhang T; Edrada-Ebel R; Henriquez FL; Roberts CW
    Sci Rep; 2017 Aug; 7(1):8247. PubMed ID: 28811501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
    Lamb DC; Warrilow AG; Rolley NJ; Parker JE; Nes WD; Smith SN; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4707-13. PubMed ID: 26014948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.
    Hargrove TY; Wawrzak Z; Alexander PW; Chaplin JH; Keenan M; Charman SA; Perez CJ; Waterman MR; Chatelain E; Lepesheva GI
    J Biol Chem; 2013 Nov; 288(44):31602-15. PubMed ID: 24047900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
    Emami S; Tavangar P; Keighobadi M
    Eur J Med Chem; 2017 Jul; 135():241-259. PubMed ID: 28456033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-Delta7-24, 25-dihydrolanosterol.
    Hargrove TY; Wawrzak Z; Liu J; Waterman MR; Nes WD; Lepesheva GI
    J Lipid Res; 2012 Feb; 53(2):311-20. PubMed ID: 22135275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain-Swap Dimerization of
    Sharma V; Shing B; Hernandez-Alvarez L; Debnath A; Podust LM
    Mol Pharmacol; 2020 Dec; 98(6):770-780. PubMed ID: 33008918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors.
    Friggeri L; Hargrove TY; Wawrzak Z; Guengerich FP; Lepesheva GI
    J Med Chem; 2019 Nov; 62(22):10391-10401. PubMed ID: 31663733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clotrimazole as a potent agent for treating the oomycete fish pathogen Saprolegnia parasitica through inhibition of sterol 14α-demethylase (CYP51).
    Warrilow AG; Hull CM; Rolley NJ; Parker JE; Nes WD; Smith SN; Kelly DE; Kelly SL
    Appl Environ Microbiol; 2014 Oct; 80(19):6154-66. PubMed ID: 25085484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals.
    Tyndall JD; Sabherwal M; Sagatova AA; Keniya MV; Negroni J; Wilson RK; Woods MA; Tietjen K; Monk BC
    PLoS One; 2016; 11(12):e0167485. PubMed ID: 27907120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design.
    Hargrove TY; Friggeri L; Wawrzak Z; Sivakumaran S; Yazlovitskaya EM; Hiebert SW; Guengerich FP; Waterman MR; Lepesheva GI
    J Lipid Res; 2016 Aug; 57(8):1552-63. PubMed ID: 27313059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.
    Hargrove TY; Wawrzak Z; Liu J; Nes WD; Waterman MR; Lepesheva GI
    J Biol Chem; 2011 Jul; 286(30):26838-48. PubMed ID: 21632531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans.
    Binjubair FA; Parker JE; Warrilow AG; Puri K; Braidley PJ; Tatar E; Kelly SL; Kelly DE; Simons C
    ChemMedChem; 2020 Jul; 15(14):1294-1309. PubMed ID: 32459374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.
    Friggeri L; Hargrove TY; Rachakonda G; Blobaum AL; Fisher P; de Oliveira GM; da Silva CF; Soeiro MNC; Nes WD; Lindsley CW; Villalta F; Guengerich FP; Lepesheva GI
    J Med Chem; 2018 Dec; 61(23):10910-10921. PubMed ID: 30451500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.
    Friggeri L; Hargrove TY; Wawrzak Z; Blobaum AL; Rachakonda G; Lindsley CW; Villalta F; Nes WD; Botta M; Guengerich FP; Lepesheva GI
    J Med Chem; 2018 Jul; 61(13):5679-5691. PubMed ID: 29894182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii.
    Shing B; Singh S; Podust LM; McKerrow JH; Debnath A
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analyses of
    Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
    J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14α-demethylase: two regions of the enzyme molecule potentiate its inhibition.
    Friggeri L; Hargrove TY; Rachakonda G; Williams AD; Wawrzak Z; Di Santo R; De Vita D; Waterman MR; Tortorella S; Villalta F; Lepesheva GI
    J Med Chem; 2014 Aug; 57(15):6704-17. PubMed ID: 25033013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential anti-acanthamoebic effects through inhibition of CYP51 by novel quinazolinones.
    Ahmed U; Ho KY; Simon SE; Saad SM; Ong SK; Anwar A; Tan KO; Sridewi N; Khan KM; Khan NA; Anwar A
    Acta Trop; 2022 Jul; 231():106440. PubMed ID: 35378058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Pyrido[4,3-
    Yan Y; Xie X; Jiang W; Bao A; Deng Z; Wang D; Wang J; Li W; Tang X
    J Agric Food Chem; 2024 May; 72(21):12260-12269. PubMed ID: 38759097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.